P

Procept Biorobotics Corp
NASDAQ:PRCT

Watchlist Manager
Procept Biorobotics Corp
NASDAQ:PRCT
Watchlist
Price: 30.5 USD -2.77%
Market Cap: 1.7B USD

Operating Margin
Procept Biorobotics Corp

-30.9%
Current
-73%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-30.9%
=
Operating Profit
-92.5m
/
Revenue
299.9m

Operating Margin Across Competitors

No Stocks Found

Procept Biorobotics Corp
Glance View

Market Cap
1.7B USD
Industry
Health Care

Procept Biorobotics Corp. is a pioneering force in the medical technology landscape, blending innovative engineering with clinical insights to address some of the most pressing challenges in urology. Founded with a vision to revolutionize surgical care, the company developed the AquaBeam Robotic System, an advanced medical platform that leverages robotic precision and real-time ultrasound imaging. This system is primarily employed in performing Aquablation therapy, a minimally invasive treatment designed to alleviate symptoms of benign prostatic hyperplasia (BPH). By integrating robotics and imaging, Procept offers a solution that enhances the accuracy of prostate tissue removal while minimizing risks and downtime for patients—a significant advancement over conventional methods. Revenue generation for Procept Biorobotics centers on the sales of their AquaBeam systems, along with consumables and service contracts that provide ongoing support and upgrades for their hospital and clinical partners. Recognizing the critical nature of procedure efficiency and safety, the company also invests in broadening the application of its technology and frequently seeks endorsements through clinical trials and studies to validate their innovations. By ensuring their cutting-edge solutions meet the stringent demands of healthcare professionals and patients alike, Procept maintains a competitive edge, fostering both adoption and trust within the healthcare community while steadily driving their growth and financial success.

PRCT Intrinsic Value
20.98 USD
Overvaluation 31%
Intrinsic Value
Price
P
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-30.9%
=
Operating Profit
-92.5m
/
Revenue
299.9m
What is the Operating Margin of Procept Biorobotics Corp?

Based on Procept Biorobotics Corp's most recent financial statements, the company has Operating Margin of -30.9%.

Back to Top